HAMBURG, Germany, June 11, 2026 /PRNewswire/ -- AIC Inc., a leading provider of enterprise storage and server solutions, will showcase its latest AI storage...
Bevington Group officially becomes Strategic Design by Argon & Co, combining design expertise with global transformation and execution capabilitySYDNEY, June 11, 2026 /PRNewswire/ --...
NEW YORK, June 10, 2026 /PRNewswire/ -- Attorneys at global law firm Greenberg Traurig, LLP represented Kayne Anderson Real Estate (Kayne Anderson) and BKM...
KNOXVILLE, TN, June 10, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (“SafeSpace Global” or the “Company”), a provider of AI-powered physical safety and security solutions for regulated care environments, today announced the launch of its new Addiction Treatment Vertical, supported by a newly executed Master Services Agreement (“MSA”) with Antidote Health Ventures and a conditional funding commitment from Method Five Labs, LLC (“Method Five Labs”).
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zillow (Z) To Contact Him Directly To Discuss Their Options
Will Serve Thousands of Long Beach Residents Each Year with Recuperative Care Services and Pathways to Stable HousingSACRAMENTO, Calif., June 10, 2026 /PRNewswire-HISPANIC PR...
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
NEW YORK, June 10, 2026 /PRNewswire/ -- MetTel, a leading provider of digital transformation and communications solutions, announced today the successful completion of a...
LONDON, June 10, 2026 /PRNewswire/ -- ICIS, a global leader in commodity intelligence, has secured exclusive access to the AMI Polymer Demand and Plastics Processors database,...
SHANGHAI, June 10, 2026 /PRNewswire/ -- Trinasolar, a global leader in smart PV and energy storage solutions, has signed a Memorandum of Understanding (MoU)...
AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.